Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. «The Long-Awaited RSV Vaccine» provides an update on RSV vaccine research. The article is published in the Journal of Interferon & Cytokine Research.
